deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT02930161

Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company

Conditions Non-alcoholic Fatty Liver Disease
Interventions Placebo Runihol
Updated 8 times since 2017 Last updated: Feb 6, 2019 Started: May 30, 2016 Primary completion: Oct 10, 2018 Completion: Oct 10, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low recruitment

Other Non-alcoholic Fatty Liver Disease trials with similar outcome

Browse all Non-alcoholic Fatty Liver Disease trials

A PHASE2 clinical study on Non-alcoholic Fatty Liver Disease, this trial is terminated or withdrawn. The trial is conducted by POLYSAN Scientific & Technological Pharmaceutical Company and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Mar 2019 — Jan 2021 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

▶ Show 3 earlier versions

  1. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  2. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

    First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • POLYSAN Scientific & Technological Pharmaceutical Company
Data source: POLYSAN Scientific & Technological Pharmaceutical Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations